Advertisement

Diagnosing and Grading of Brain Tumors: Immunohistochemistry

  • Hidehiro TakeiEmail author
  • Suzanne Z. Powell
Chapter
Part of the Methods of Cancer Diagnosis, Therapy and Prognosis book series (HAYAT, volume 8)

Abstract

Diagnostic neuro-oncology practice has benefited in the last 2 decades from the incorporation of, and recent advances in, immunohistochemistry (IHC). Although the mainstay of brain tumor diagnosis including its grading remains conventional hematoxylin-eosin (H&E)-stained histology, it is no doubt that IHC plays a major role in differential diagnosis and in improving the diagnostic accuracy. It is generally used for purposes of (1) identifying tumor cell type/origin, (2) assessing cell proliferation potential, (3) evaluating the boundary between tumor and the surrounding tissue (i.e., tumor “margin”), and (4) excluding reactive processes (e.g., demyelinating and infectious diseases). In the future, novel antibodies utilized as prognostic, predictive markers and as potential therapeutic targets for brain tumors will be developed.

Keywords

Glial Fibrillary Acidic Protein Pilocytic Astrocytoma Epithelial Membrane Antigen Solitary Fibrous Tumor Central Neurocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCES

  1. Amatya, V.J., Takeshima, Y., Sugiyama, K., Kurisu, K., Nishisaka, T., Fukuhara, T., and Inai, K. (2001) Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum. Pathol. 32:970–975PubMedCrossRefGoogle Scholar
  2. Bhattacharjee, M.B., Adesina, A.M., Goodman, J.C., and Powell, S.Z. (2003) Claudin-1 expression in meningiomas and schwannomas: possible role in differential diagnosis (abstract). J. Neuropathol. Exp. Neurol. 62:581Google Scholar
  3. Biegel, J.A. (2006) Molecular genetics of atypical teratoid/rhabdoid tumors. Neurosurg. Focus 20: 1–7CrossRefGoogle Scholar
  4. Bouffard, J.P., Sandberg, G.D., Golden, J.A., and Rorke, L.B. (2004) Double immunolabeling of central nervous system atypical teratoid/rhabdoid tumors. Mod. Pathol. 17:679–683PubMedCrossRefGoogle Scholar
  5. Buslei, R., Nolde, M., Hofmann, B., Meissner, S., Eyupoglu, I.Y., Siebzehnrubl, F., Hahnen, E., Kreutzer, J., and Fahlbusch, R. (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumors originating from the sellar region. Acta Neuropathol. 109:589–597PubMedCrossRefGoogle Scholar
  6. Colman, H., Giannini, C., Huang, L., Gonzalez, J., Hess, K., Bruner, J., Fuller, G., Langford, L., Pelloski, C., Aaron, J., Burger, P., and Aldape, K. (2006) Assessment and prognosis significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am. J. Surg. Pathol. 30:657–664PubMedCrossRefGoogle Scholar
  7. de Chadarevian, J.P., Halligan, G.E., Reddy, G., Bertrand, L., Pascasio, J.M., Faerber, E.N., and Katsetos, C.D. (2006) Glioneuronal phenotype in a diencephalic pilomyxoid astrocytoma. Pediatr. Dev. Pathol. 9:480–487PubMedCrossRefGoogle Scholar
  8. Fuller, C.E., Frankel, B., Smith, M., Rodziewitz, G., Landas, S.K., Caruso, R., and Schelper, R. (2001) Suprasellar monomorphous pilomyxoid neoplasm: an ultrastructural analysis. Clin. Neuropathol. 20:256–262PubMedGoogle Scholar
  9. Hahn, H.P., Bundock, E.A., and Hornick, J.L. (2006) Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics. Am. J. Clin. Pathol. 125:203–208PubMedGoogle Scholar
  10. Hasselblatt, M., and Paulus, W. (2003) Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas. Acta Neuropathol. (Berlin) 4:385–388CrossRefGoogle Scholar
  11. Hirose, T., Scheithauer, B.W., Lopes, M.B.S., Gerber, H.A., Altermatt, H.J., and VandenBerg, S.R. (1997) Ganglioglioma: an ultrastructural and immunohistochemical study. Cancer 79:989–1003PubMedCrossRefGoogle Scholar
  12. Hofmann, B.M., Kreutzer, J., Saeger, W., Buchfelder, M., Blumcke, I., Fahlbusch, R., and Buslei, R. (2006) Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and Rathke cleft cysts: a clinico-pathologic approach. Am. J. Surg. Pathol. 30:1595–1603PubMedCrossRefGoogle Scholar
  13. Jarrell, S.T., Vortmeyer, A.O., Linehan, W.M., Oldfield, E.H., and Lonser, R.R. (2006) Metastases to hemangioblastomas in von Hippel-Lindau disease. J. Neurosurg. 105:256–263PubMedCrossRefGoogle Scholar
  14. Johannessen, A.L., and Torp, S.H. (2006) The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas. Pathol. Oncol. Res. 12:143–147PubMedCrossRefGoogle Scholar
  15. Judkins, A.R., Burger, P.C., Hamilton, R.L., DeMasters, B.-K., Perry, A., Pomeroy, S.L., Rosenblum, M.K., Yachnis, A.T., Zhou, H., Rorke, L.B., and Biegel, J.A. (2005) INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J. Neuropathol. Exp. Neurol. 64:391–397PubMedGoogle Scholar
  16. Katsetos, C.D., Del Valle, L., Geddes, J.F., Assimakopoulou, M., Legido, A., Boyd, J.C., Balin, B., Parikh, N.A., Maraziotis, T., de Chadarevian, J.P., Varakis, J.N., Matsas, R., Spano, A., Frankfurter, A., Herman, M.M., and Khalili, K. (2001) Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch. Pathol. Lab. Med. 125:613–624PubMedGoogle Scholar
  17. Liu, Y., Sturgis, C.D., Bunker, M., Saad, R.S., Tung, M., Raab, S.S., and Silverman, J.F. (2004) Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma. Mod. Pathol. 17:1129–1133PubMedCrossRefGoogle Scholar
  18. Louis, D.N., Ohgaki, H., Wiestler, O.D., and Cavenee, W.K. (eds) (2007) WHO classification of tumours of the central nervous system. IARC Press, Lyon, FranceGoogle Scholar
  19. Maraziotis, T., Perentes, E., Karamitopoulou, E., Nakagawa, Y., Gessaga, E.C., Probst, A., and Frankfurter, A. (1992) Neuron-associated class II beta tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases. Acta Neuropathol. 84:355–363PubMedCrossRefGoogle Scholar
  20. Martinez-Diaz, H., Kleinschmidt-DeMasters, B.K., Powell, S.Z., and Yachnis, A.T. (2003) Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch. Pathol. Lab. Med. 127:1187–1191PubMedGoogle Scholar
  21. Matsuno, A., Fujimaki, T., Sasaki, T., Nagashima, T., Ide, T., Asai, A., Matsuura, R., Utsunomiya, H., and Kurino, T. (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol. 91:504–510PubMedCrossRefGoogle Scholar
  22. McLendon, R.E., Friedman, H.S., Fuchs, H.E., Kun, L.E., and Bigner, S.H. (1999) Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study. Histopathology 34:154–162PubMedCrossRefGoogle Scholar
  23. Miettinen, M., and Paetau, A. (2002) Mapping of the keratin polypeptides in meningiomas of different types: an immunohistochemical analysis of 463 cases. Hum. Pathol. 33:590–598PubMedCrossRefGoogle Scholar
  24. Min, H.S., Lee, Y.J., Park, K., Cho, B.-K., and Park, S.-H. (2006) Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior. Acta Neuropathol. 112:13–20PubMedCrossRefGoogle Scholar
  25. Patil, S., Perry, A., MacCollin, M., Dong, S., Betensky, R.A., Yeh, T.-H., Gutmann, D.H., and Stemmer-Rachamimov, A.O. (2008) Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol. 18:517–519PubMedGoogle Scholar
  26. Perry, A., Scheithauer, B.W., and Nascimento, A.G. (1997) The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am. J. Surg. Pathol. 21:1354–1360PubMedCrossRefGoogle Scholar
  27. Perry, A., Stafford, S.L., Scheithauer, B.W., Suman, V.J., and Lohse, C.M. (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRefGoogle Scholar
  28. Preusser, M., Laggner, U., Haberler, C., Heinzl, H., Budka, H., and Hainfellner, J.A. (2006) Comparative analysis of NeuN immunoreactivity in primary brain tumors: conclusions for rational use in diagnostic histopathology. Histopathology 48:438–444PubMedCrossRefGoogle Scholar
  29. Ribalta, T., McCutcheon, I.E., Aldape, K.D., Bruner, J.M., and Fuller, G.N. (2004) The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am. J. Surg. Pathol. 28:1532–1536PubMedCrossRefGoogle Scholar
  30. Sharma, M.C., Ralte, A.M., Gaekwad, S., Santosh, V.,Shankar, S.K., and Sarkar, C. (2004) Subependymal giant cell astrocytoma- a clinicopathological study of 23 cases with special emphasis on histogenesis. Pathol. Oncol. Res. 10:219–224PubMedCrossRefGoogle Scholar
  31. Takei, H., Buckleair, L.W., and Powell, S.Z. (2008) Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Neuropathology 28:62–68PubMedCrossRefGoogle Scholar
  32. Vege, K.D., Giannini, C., and Scheithauer, B.W. (2000) The immunophenotype of ependymomas. Appl. Immunohistochem. Mol. Morphol. 8:25–31PubMedCrossRefGoogle Scholar
  33. Weinbreck, N., Marie, B., Bressenot, A., Montagne, K., Joud, A., Baumann, C., Klein, O., and Vignaud, J.M. (2008) Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear cell renal cell carcinoma in the brain: utility of aquaporin 1 combined with cytokeratin AE1/AE3 immunostaining. Am. J. Surg. Pathol. 32:1051–1059PubMedCrossRefGoogle Scholar
  34. Wharton, S.B., Chan, K.K., and Whittle, I.R. (2002) Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. J. Clin. Neurosci. 9:165–169PubMedCrossRefGoogle Scholar
  35. Wolf, H.K., Buslei, R., Blumcke, I., Wiesler, O.D., and Pietsch, T. (1997) Neuronal antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors. Acta Neuropathol. 94:436–443PubMedCrossRefGoogle Scholar

Copyright information

© Springer Netherlands 2011

Authors and Affiliations

  1. 1.Department of PathologyBaylor College of MedicineHoustonUSA

Personalised recommendations